支持性表达疗法对淋巴瘤患者恐惧疾病进展和心理韧性的影响  

Effect of supportive-expressive therapy on fear of progression and resilience in lymphoma patients

作　　者：胡雁 赵晓茜[1] 范磊[1] Hu Yan;Zhao Xiaoqian;Fan Lei(Department of Hematology,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China)

机构地区：[1]南京医科大学第一附属医院血液科,南京210029

出　　处：《中国实用护理杂志》2022年第17期1287-1291,共5页Chinese Journal of Practical Nursing

基　　金：江苏省级自然科学基金优秀青年项目(BK20160099);江苏省"六大人才高峰计划"(WSN-035)。

摘　　要：目的探讨支持性表达疗法(SET)对淋巴瘤患者恐惧疾病进展和心理韧性的影响,为临床护理提供参考。方法选取2019年2月至2020年9月南京医科大学第一附属医院收治的86例淋巴瘤患者,按照随机数字表法分为试验组和对照组,每组43例。对照组给予常规护理,试验组在常规护理基础上接受6次SET干预。使用恐惧疾病进展简化量表(FoP-Q-SF)和Connor-Davidson韧性量表(CF-RISC)对2组患者恐惧疾病进展程度和心理韧性进行测量。结果最终试验组纳入40例,对照组纳入42例。干预前2组患者FoP-Q-SF及CF-RISC各维度及总分比较差异无统计学意义(均P>0.05)。干预后,试验组FoP-Q-SF中生理健康维度、社会家庭维度评分及总分分别为(14.90±3.96)、(15.03±4.29)、(29.93±5.65)分,明显低于对照组的(17.71±3.38)、(17.29±4.03)、(35.00±5.57)分,差异有统计学意义(t=3.47、2.46、4.10,均P<0.05);干预后试验组CF-RISC中坚韧、力量、乐观维度得分及总分分别为(28.08±4.47)、(21.30±5.58)、(10.65±2.97)、(60.03±8.42)分,明显高于对照组的(24.31±4.11)、(17.98±4.13)、(9.26±2.47)、(51.55±5.86)分,差异有统计学意义(t值为2.30~5.27,均P<0.05)。结论SET干预可有效降低淋巴瘤患者恐惧疾病进展程度,提升患者心理韧性水平。Objective To explore the effect of supportive-expressive therapy(SET)on fear of progression and resilience in lymphoma patients,to provide reference for clinical nursing care.Methods A total of 86 patients with lymphoma treated in the First Affiliated Hospital of Nanjing Medical University from February 2019 to September 2020 were divided into experimental group and control group according to random number table method,with 43 cases in each group.The control group was given conventional nursing,while the experimental group was applied with 6 times SET.Before and after intervention,the Fear of Progression Questionnaire-Short Form(FoP-Q-SF)and Connor Davidson Resilience Scale(CD-RISC)was evaluated between two groups.Results Finally,40 cases were included in the experimental group and 42 cases in the control group.There was no significant difference between each dimension and total score of the two groups before intervention(P>0.05).After intervention,scores of physiological health dimension,social and family dimension,and total FoP-Q-SF were(14.90±3.96)points,(15.03±4.29)points and(29.93±5.65)points in the experimental group,significantly lower than those in the control group(17.71±3.38)points,(17.29±4.03)points and(35.00±5.57)points(t=3.47,2.46,4.10,all P<0.05);scores of tenacity,strength,optimism dimension and total CD-RISC were(28.08±4.47)points,(21.30±5.58)points,(10.65±2.97)points and(60.03±8.42)points in the experimental group,significantly higher than those in the control group(24.31±4.11)points,(17.98±4.13)points,(9.26±2.47)points and(51.55±5.86)points,the differences were statistically significant(t values were 2.30-5.27,all P<0.05).Conclusions SET can effectively alleviate the degree of fear of progression and promote resilience of lymphoma patients.

关 键 词：淋巴瘤 支持性表达疗法 恐惧疾病进展 心理韧性 

分 类 号：R473.73[医药卫生—护理学]